neoplasm, granular and epithelial
Showing 1 - 25 of 2,453
Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)
Recruiting
- Carcinoma, Ovarian Epithelial
- +8 more
- AB-1015
-
Iowa City, IowaU. of Iowa Health Care
Jan 30, 2023
Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)
Completed
- Carcinoma
- +12 more
- Ocoxin-Viusid
-
Havana, CubaNational Institute of Oncology and Radiobiology (INOR)
Jul 5, 2022
Metastatic Cancer, Epithelial Tumor Trial in United States (NG-641)
Recruiting
- Metastatic Cancer
- Epithelial Tumor
- NG-641
-
Los Angeles, California
- +5 more
Jan 16, 2023
Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)
Not yet recruiting
- Ovarian Cancer
- +5 more
- MIRRORS Protocol
- Standard Open Cytoreductive Surgery
- (no location specified)
Jul 17, 2023
Tumor Recurrence, Malignant Epithelial Tumor of Vulva, Malignant Epithelial Tumor of Ovary Trial in Pavia (carbon ion radiation
Recruiting
- Tumor Recurrence
- +3 more
- carbon ion radiation therapy
-
Pavia, Pv, ItalyCNAO
Jul 13, 2022
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +22 more
- Laboratory Biomarker Analysis
- Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Oct 7, 2022
Ovarian Tumor Epithelial Trial (acute normovolemic hemodilution (ANH), acute hypervolemic hemodilution (AHH))
Completed
- Ovarian Neoplasm Epithelial
- acute normovolemic hemodilution (ANH)
- acute hypervolemic hemodilution (AHH)
- (no location specified)
Oct 21, 2023
Metastatic Cancer, Epithelial Tumor Trial in Santa Monica, Liverpool, Oxford (NG-641 in combination with Nivolumab)
Recruiting
- Metastatic Cancer
- Epithelial Tumor
- NG-641 in combination with Nivolumab
-
Santa Monica, California
- +2 more
Mar 16, 2022
Ovarian Tumor Epithelial, Ovarian Cancer, Fallopian Tube Tumors Trial in India (Oregovomab, Paclitaxel, Carboplatin)
Not yet recruiting
- Ovarian Neoplasm Epithelial
- +4 more
- Oregovomab
- +3 more
-
Visakhapatnam, Andhra Pradesh, India
- +7 more
Dec 7, 2022
Endocrine Disruptors and Life STILe in Breast Cancer Development
Recruiting
- Breast Cancer
- +5 more
-
Roma, ItalyAlessandra Fabi
Feb 25, 2023
Ovarian Cancer, Drug Related Tumor/Cancer Trial (secondary cytoreductive surgery, chemo)
Not yet recruiting
- Ovarian Cancer
- Drug Related Neoplasm/Cancer
- secondary cytoreductive surgery
- chemotherapy
- (no location specified)
Jan 28, 2023
Carcinoma, Neoplasia; Intraepithelial, Cervix, Glandular Tumors Trial in Havana (Glizigen® + Ocoxin-Viusid®)
Recruiting
- Carcinoma
- +4 more
- Glizigen® + Ocoxin-Viusid®
-
Havana, CubaOur Lady of Rule No. 52 &/Remedios and Quiroga, Luyano
Jul 5, 2022
Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor
Recruiting
- Advanced Malignant Solid Neoplasm
- +7 more
- BET Bromodomain Inhibitor ZEN-3694
- Talazoparib
-
Atlanta, Georgia
- +2 more
Nov 3, 2022
Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)
Not yet recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023
Malignant Tumor of Ovary, Malignant Tumor of Fallopian Tube, Malignant Tumor of Peritoneum Trial in Charlotte, Cleveland
Completed
- Malignant Neoplasm of Ovary
- +2 more
- Diagnostic laparoscopy
-
Charlotte, North Carolina
- +1 more
Mar 11, 2022
ResiduAl Cancer With Liquid Biopsy Evaluation
Recruiting
- Bladder Carcinoma
- +14 more
- Guardant Reveal
-
Redwood City, CaliforniaRedwood City
Sep 7, 2022
Improved Diagnosis of Ovarian Cancer
Recruiting
- Ovarian Neoplasms
- +6 more
-
Aarhus, DenmarkDepartment of Gynaecology and Obstetrics, Aarhus University Hosp
May 1, 2023
Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed
Completed
- Ovarian Neoplasm
- +4 more
- (no location specified)
Aug 22, 2022
Sarcomas, Melanomas, Germ Cell Tumors Trial run by the NCI (AeroEclipse II Breath Actuated Nebulizer, Bintrafusp alfa,
Withdrawn
- Sarcomas
- +4 more
- AeroEclipse II Breath Actuated Nebulizer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 16, 2021
Patients With Low Grade Ovarian or Peritoneal Tumors
Recruiting
- Low Grade Ovarian Serous Adenocarcinoma
- +5 more
- Biospecimen Collection
- Electronic Health Record Review
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt
Unknown status
- Esophageal Neoplasms
- +2 more
- Endoscopic ultrasound
-
Kafr Ash Shaykh, Kafrelsheikh, EgyptKafrelsheikh University
Aug 30, 2021
Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,
Not yet recruiting
- Solid Tumors
- +8 more
- Magnetic Resonance-Guided High Intensity Focused Ultrasound
- Lyso-thermosensitive Liposomal Doxorubicin
- (no location specified)
Mar 10, 2022
Ovarian Cancer, Endometrial Cancer, Ovary Tumor Trial in Multiple Locations (Physician's choice according to patient's needs.)
Recruiting
- Ovarian Cancer
- +6 more
- Physician's choice according to patient's needs.
-
Multiple Locations, GermanyMultiple sites all over Germany
Dec 1, 2021